Imatinib Krka d.d. 400 mg Dispersible tablets

Licence status
Withdrawn: 23/11/2021
Active substances
Imatinib
Dosage Form
Dispersible tablet
Licence number
PA1347/054/004
Licence holder
KRKA, d.d., Novo mesto

Product documents

Licence information

ATC code
L01XE Protein kinase inhibitors, L01XE01 imatinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/09/2017